ALVOGEN FDA Approval ANDA 204595

ANDA 204595

ALVOGEN

FDA Drug Application

Application #204595

Application Sponsors

ANDA 204595ALVOGEN

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL400MG0FELBAMATEFELBAMATE
002TABLET;ORAL600MG0FELBAMATEFELBAMATE

FDA Submissions

UNKNOWN; ORIG1AP2016-01-11

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ALVOGEN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204595
            [companyName] => ALVOGEN
            [docInserts] => ["",""]
            [products] => [{"drugName":"FELBAMATE","activeIngredients":"FELBAMATE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FELBAMATE","activeIngredients":"FELBAMATE","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/11\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-01-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.